DAPK1 also affects signaling pathways involved in tumor initiation and progression, such as Wnt/β-catenin, NF-κB, and MAPK pathways, impacting tumor proliferation, invasion, metastasis, and drug resistance. Here, DAPK1 is linked to neoplasm.